You have 9 free searches left this month | to do more
Showing 1 - 25 of
619 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects - 2020
Completed
  • Recurrent/Refractory Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Guiyang, Guizhou, China
    Guizhou Cancer Hospita
2021-12-12
Dec 12, 2021
C
Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM
Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
2022-01-16
Jan 16, 2022
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
Not yet recruiting
  • Advanced Pancreatic Cancer
  • Mitoxantrone Hydrochloride Liposome injection
  • (no location specified)
2021-10-19
Oct 19, 2021
C
A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor
Not yet recruiting
  • Advanced Malignant Tumor
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
2021-10-09
Oct 9, 2021
C
Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL
Recruiting
  • Treatment-naïve
  • Peripheral T Cell Lymphoma
  • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2021-07-26
Jul 26, 2021
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors
Not yet recruiting
  • Advanced Solid Tumors
  • Mitoxantrone Hydrochloride Liposome injection
  • Baoding, Hebei, China
    Affiliated Hospital of Hebei University
2021-06-04
Jun 4, 2021
I
GVM±R in Patients With Relapsed or Refractory Aggressive NHL
Not yet recruiting
  • Non Hodgkin Lymphoma
  • Liposomal Mitoxantrone Hydrochloride dose level 1
  • +6 more
  • (no location specified)
2022-03-17
Mar 17, 2022
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers
Not yet recruiting
  • Recurrent Head and Neck Cancer
  • Metastatic Head and Neck Cancer
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • (no location specified)
2021-05-20
May 20, 2021
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma
Not yet recruiting
  • Unresectable or Metastatic Bone and Soft Tissue Sarcoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
2021-05-20
May 20, 2021
C
A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Not yet recruiting
  • Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride liposome injection
  • Cytarabine (LoDAC)
  • Guiyang, Guizhou, China
    The Affiliated Hospital of Guizhou Medical University
2021-10-19
Oct 19, 2021
N
Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
2021-10-29
Oct 29, 2021
W
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Active, not recruiting
  • Granulocytic Sarcoma
  • Recurrent Adult Acute Myeloid Leukemia
  • 6,8-Bis(benzylthio)octanoic Acid
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2022-01-03
Jan 3, 2022
C
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL
Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
2020-12-11
Dec 11, 2020
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor
Active, not recruiting
  • Advanced Solid Tumor
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • Bengbu, Anhui, China
  • +7 more
2021-10-28
Oct 28, 2021
F
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine and Mitoxantrone in Treating Participants With Previously Untreated Acute Myeloid Leukemia or High-Grade Myeloid Neoplasm
Active, not recruiting
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-07-06
Jul 6, 2021
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer
Recruiting
  • Platinum-resistant Ovarian Cancer
  • Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
  • Chongqing, Chongqing, China
  • +6 more
2021-05-31
May 31, 2021
C
Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL
Not yet recruiting
  • Extranodal NK/T-cell Lymphoma, Nasal Type
  • Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase
  • +2 more
  • (no location specified)
2020-08-09
Aug 9, 2020
S
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
Completed
  • Neuromyelitis Optica
  • +3 more
  • Mitoxantrone
  • Buffalo, New York
    Baird Multiple Sclerosis Center
2020-12-23
Dec 23, 2020
C
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma
Recruiting
  • Advanced Gastric Carcinoma
  • Mitoxantrone Hydrochloride Liposome, intravenous injection
  • Beijing, Beijing, China
  • +8 more
2021-05-31
May 31, 2021
U
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-07
Feb 7, 2022
U
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm - 2021
Completed
Has Results
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-23
Feb 23, 2022
T
Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
Recruiting
  • Relapsed Adult AML
  • Venetoclax Oral Tablet
  • Dresden, Germany
  • +5 more
2021-09-06
Sep 6, 2021
C
A Study to Evaluate the Safety and Efficacy of PLM60 in Advanced HCC
Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Liposome-entrapped Mitoxantrone Hydrochloride Injection
  • (no location specified)
2021-06-14
Jun 14, 2021
P
Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD
Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
2021-01-04
Jan 4, 2021
I
Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis - 2012
Completed
Has Results
  • Multiple Sclerosis
  • plasmapheresis
  • Isfahan, Iran, Islamic Republic of
    Alahra hospital
2020-08-27
Aug 27, 2020